| Followers | 35 |
| Posts | 1912 |
| Boards Moderated | 0 |
| Alias Born | 11/05/2020 |
Sunday, February 01, 2026 8:59:21 AM
Nothing I said was a lie.
The procedure happened in December 2024. The video was done in March 2025. That is roughly 90 days post-treatment.
The first thing I wouldn't do is believe someone who has hyped up or lied in PRs and social media posts. Like I always say, there is a way of giving information without giving information.
Papillary thyroid cancer is usually slow growing. A 90-day post-treatment announcement is hardly the justification of "undetectable." If the procedure began in December 2024 and the "results" were shared March 2025, what is her remission rate right now in February 2026?
That information doesn't relieve the fact that the other 20% was ever destroyed either because:
Imaging techniques also face limitations; some tumors can be too small, diffuse, or located in areas difficult to visualize clearly. Big factors that certainly go with this type of medical indication.
Either way, India has paused it. And the FDA saw all the data from that trial to still reject it.
The procedure happened in December 2024. The video was done in March 2025. That is roughly 90 days post-treatment.
The first thing I wouldn't do is believe someone who has hyped up or lied in PRs and social media posts. Like I always say, there is a way of giving information without giving information.
Papillary thyroid cancer is usually slow growing. A 90-day post-treatment announcement is hardly the justification of "undetectable." If the procedure began in December 2024 and the "results" were shared March 2025, what is her remission rate right now in February 2026?
That information doesn't relieve the fact that the other 20% was ever destroyed either because:
Imaging techniques also face limitations; some tumors can be too small, diffuse, or located in areas difficult to visualize clearly. Big factors that certainly go with this type of medical indication.
Either way, India has paused it. And the FDA saw all the data from that trial to still reject it.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
